← Evidence map

ArticlePloS one2020

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results.

Afschin GandjourPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33006987